Skip to main content
Clinical Trials/NCT04381767
NCT04381767CompletedNot Applicable

EYE-SYNC Concussion Classification Study

Sync-Think, Inc.1 site in 1 country1,303 target enrollmentStarted: December 19, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,303
Locations
1
Primary Endpoint
A change in metrics of eye movement that enable positive concussion detection using EYE-SYNC metrics

Study Overview

Brief Summary

The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for sport-related concussion evaluation.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
17 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Men and women actively engaged in competitive athletics
  • Eye tracking measurements and SCAT5 evaluations are collected within 3-day window
  • Eye tracking measurements and SCAT5 evaluations are collected within 3 days of injury

Exclusion Criteria

  • Prior enrollment (subjects may only enroll once)
  • POOR eye tracking data quality
  • Subjects without reported injury detailing alteration of consciousness (AOC) or altered mental status (AMS) defined as self-report, witness report or the following responses to the SCAT5 SSS: "Difficulty Remembering" ≥ 4 or "Confusion" ≥ 4, or scored less than 23 on the SCAT5 Standardized Assessment of Concussion (SAC) or greater than 25 on the SCAT5 Symptom Severity Score (SSS)
  • EYE-SYNC smooth pursuit standard deviation of tangential error (SDTE) variance scores < 2.0

Outcomes

Primary Outcomes

A change in metrics of eye movement that enable positive concussion detection using EYE-SYNC metrics

Time Frame: 3 days

A True Positive and True Negative rate for identifying Concussion as compared to a Clinical Reference standard.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sync-Think, Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials